Worcester, MA, United States of America

Seth Ribe

USPTO Granted Patents = 2 


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Seth Ribe

Introduction

Seth Ribe is an accomplished inventor based in Worcester, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological disorders. With a total of 2 patents to his name, Ribe's work is paving the way for new treatment options.

Latest Patents

Seth Ribe's latest patents include "Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors" and "Phenyl-substituted cyclohexylamine derivatives and method for their synthesis and characterization." These patents disclose the use of these compounds to treat and prevent neurological disorders. The exemplary compounds inhibit the reuptake of endogenous monoamines, such as dopamine, serotonin, and norepinephrine, from the synaptic cleft. Additionally, they modulate one or more monoamine transporters. The patents also provide pharmaceutical formulations that incorporate these innovative compounds.

Career Highlights

Seth Ribe is currently employed at Sunovion Pharmaceuticals Inc., where he continues to advance his research and development efforts. His work focuses on creating effective treatments for neurological conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Some of his notable coworkers include Liming Shao and Fengjiang Wang, who contribute to the collaborative efforts in research and development at Sunovion Pharmaceuticals Inc.

Conclusion

Seth Ribe's innovative work in the field of pharmaceuticals highlights his commitment to addressing neurological disorders through novel compounds. His patents represent a significant step forward in the development of effective treatments, showcasing the impact of his research on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…